COVID-19 research at MORU
Summary of the COVID research at MORU
COPCOV trial
COPCOV is a randomised, placebo-controlled prophylaxis study to determine whether chloroquine or hydroxychloroquine prevents coronavirus disease (COVID-19) in the healthcare setting.
SEBCOV study
SEBCOV aims to produce evidence to inform public health measures such as communications, quarantine, self-isolation, social distancing, travel restrictions and other for the COVID-19 pandemic.